GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype.
Paret C, Ustjanzew A, Ersali S, Seidmann L, Jennemann R, Ziegler N, Malki KE, Russo A, Wingerter A, Ortmüller F, Bornas A, Wehling PC, Lepădatu A, Ottenhausen M, Roth W, Sommer C, Fliss B, Frauenknecht KBM, Sandhoff R, Faber J.
Paret C, et al.
Cancers (Basel). 2022 Dec 8;14(24):6051. doi: 10.3390/cancers14246051.
Cancers (Basel). 2022.
PMID: 36551537
Free PMC article.